Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex

Abstract

It has been reported that metastasis-associated gene 1 (Mta1) is overexpressed in many malignant tumors with high metastatic potential. In addition, some studies indicated that MTA1 participated in invasion, metastasis, and survival of cancer cells by regulating cell migration, adhesion and proliferation. But the role of MTA1 is unclear in vitro in the development of cervical cancer cells. This study investigated whether and how MTA1 mediated cell proliferation, migration, invasion and adhesion in cervical cancer. MTA1 expression level was detected by Western blot in two cervical cancer cell lines of different invasion potentials. The effects of MTA1 expression on SiHa cell apoptosis, cycle, proliferation, migration, invasion and adhesion were tested by flow cytometry, MTT, wound-healing assay, Transwell assay and adhesion assay, respectively. The expression levels of p53, E-cadherin, and β-catenin activity were evaluated in untreated and treated cells. The results showed that MTA1 protein expression was significantly higher in SiHa than in HeLa, which was correlated well with the potential of migration and invasion in both cell lines. Furthermore, the cell invasion, migration and adhesion capabilities were decreased after inhibition of MTA1 expression mediated by Mta1-siRNA transfection in SiHa. However, no significant differences were found in cell apoptosis, cycle, and proliferation. In addition, E-cadherin and p53 protein levels were significantly up-regulated, while β-catenin was significantly down-regulated in SiHa transfected with the siRNA. These results demonstrated that MTA1 played an important role in the migration and invasion of cervical cancer cells. It was speculated that the decreased migration and invasion capability by inhibiting the MTA1 expression in the SiHa cell line may be mediated through the altered expression of p53, and E-cadherin/β-catenin complex. MTA1 could serve as a potential therapeutic target in cervical cancer.

Keywords

metastasis-associated gene 1 / RNA interference / cervical cancer / invasion / migration

References

[1] Global Cancer Facts and Figures: Estimated Number of New Cancer Cases by World Area, 2007. 2007: Page 3, Figure 1. (Accessed January 26, 2008 at http://www.cancer.org/downloads/STT/Global Cancer Facts and Figures 2007 rev.pdf)

[2] LiJ., JiaH., XieL., et al.. Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma. Gynecol Oncol, 2009, 114(1): 89-93

[3] KumarJ.V., DovalD.C., RaoR., et al.. A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery. Int J Gynecol Cancer, 2009, 19(3): 417-422

[4] TohY., PencilS.D., NicolsonG.L.. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem, 1994, 269(37): 22 958-22 963

[5] TohY., NicolsonG.L.. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis, 2009, 26(3): 215-227

[6] NicolsonG.L., NawaA., TohY., et al.. Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis, 2003, 20(1): 19-24

[7] MartinM.D., HilsenbeckS.G., MohsinS.K., et al.. Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Res Treat, 2006, 95(1): 7-12

[8] KawasakiG., YanamotoS., YoshitomiI., et al.. Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: correlation with metastasis and invasion. Int J Oral Maxillofac Surg, 2008, 37(11): 1039-1046

[9] TohY., KuwanoH., MoriM., et al.. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer, 1999, 79(11–12): 1723-1726

[10] TohY., OkiE., OdaS., et al.. Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer, 1997, 74(4): 459-463

[11] KiddM., ModlinI.M., ManeS.M., et al.. The role of genetic markers-NAP1L1, MAGE-D2, and MTA1-in defining small-intestinal carcinoid neoplasia. Ann Surg Oncol, 2006, 13(2): 253-262

[12] MiyakeK., YoshizumiT., ImuraS., et al.. Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas, 2008, 36(3): e1-9

[13] RyuS.H., ChungY.H., LeeH., et al.. Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology, 2008, 47(3): 929-936

[14] BalasenthilS., BroaddusR.R., KumarR.. Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Hum Pathol, 2006, 37(6): 656-661

[15] DannenmannC., ShabaniN., FrieseK., et al.. The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biol Ther, 2008, 7(9): 1460-1467

[16] SasakiH., MoriyamaS., NakashimaY., et al.. Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer, 2002, 35(2): 149-154

[17] HoferM.D., KueferR., VaramballyS., et al.. The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res, 2004, 64(3): 825-829

[18] SasakiH., YukiueH., KobayashiY., et al.. Expression of the MTA1 mRNA in thymoma patients. Cancer Lett, 2001, 174(2): 159-163

[19] QianH., YuJ., LiY., et al.. RNA interference of metastasis-associated gene 1 inhibits metastasis of B16F10 melanoma cells in a C57BL/6 mouse model. Biol Cell, 2007, 99(10): 573-581

[20] HoferM.D., TapiaC., BrowneT.J., et al.. Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue. Arch Pathol Lab Med, 2006, 130(7): 989-996

[21] WeiX., ChenK.. Expression of MTA1 protein in the squamous carcinoma of the cervix and its significance. Clin Med (Chinese), 2007, 9(09): 77-78

[22] FuL., XiongX.. Expression of MTA1 gene in cervical cancer tissues and its clinical significance. Chin J Maternal Child Health Res (Chinese), 2006, 5(05): 349-351

[23] NawaA., NishimoriK., LinP., et al.. Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J Cell Biochem, 2000, 79(2): 202-212

[24] QianH., LuN., XueL., et al.. Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line. Clin Exp Metastasis, 2005, 22(8): 653-662

[25] ScheffnerM., WernessB.A., HuibregtseJ.M., et al.. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 1990, 63(6): 1129-1136

[26] MoodyC.A., LaiminsL.A.. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer, 2010, 10(8): 550-560

[27] LiW., BaoW., MaJ., et al.. Metastasis tumor antigen 1 is involved in the resistance to heat stress-induced testicular apoptosis. FEBS Lett, 2008, 582(6): 869-873

[28] LiD.Q., PakalaS.B., ReddyS.D., et al.. Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. J Biol Chem, 2010, 285(13): 10 044-10 052

[29] LiD.Q., DivijendraN.R., PakalaS.B., et al.. MTA1 coregulator regulates p53 stability and function. J Biol Chem, 2009, 284(50): 34 545-34 552

[30] BonitsisN., BatistatouA., KarantimaS., et al.. The role of cadherin/catenin complex in malignant melanoma. Exp Oncol, 2006, 28(3): 187-193